Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience (UB Neuro), Department of Medicine, Facultat de Medicina i Ciències de la Salut, University of Barcelona, Fundació Clínic per la Recerca Biomèdica-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FCRB-IDIBAPS), CIBERSAM-ISCIII, Barcelona, Catalonia, Spain; Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain; Hospital Universitario Jerez de la Frontera, University of Cádiz, Cádiz, Spain.
Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience (UB Neuro), Department of Medicine, Facultat de Medicina i Ciències de la Salut, University of Barcelona, Fundació Clínic per la Recerca Biomèdica-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FCRB-IDIBAPS), CIBERSAM-ISCIII, Barcelona, Catalonia, Spain; Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain; Barcelona Clinic Schizophrenia Unit, Hospital Clinic de Barcelona, Departament de Medicina, Institut de Neurociències (UBNeuro), Universitat de Barcelona (UB), FCRB-IDIBAPS), CIBERSAM-ISCIII, Barcelona, Spain; Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), CIBERSAM-ISCIII, Barcelona, Catalonia, Spain; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
J Affect Disord. 2025 Jan 15;369:449-461. doi: 10.1016/j.jad.2024.10.002. Epub 2024 Oct 3.
This study was aimed at identifying sex differences in patients presenting a first episode mania (FEM) or psychosis (FEP) to help shaping early treatment strategies focused on sex differences.
Patients with a FEM or FEP underwent a clinical, neuropsychological (neurocognitive functions and emotional intelligence) and functional assessment. Performance on those variables was compared between groups through general linear model, with sex and group (FEM vs FEP) as main effects and group by sex interactions.
The total sample included 113 patients: FEM = 72 (45.83 % females) and FEP = 41 (46.34 % females). There were significant main effects for group (not for sex) for most of the clinical features (depressive, negative and positive symptoms) and psychosocial functioning (χ = 8.815, p = 0.003). As for neuropsychological performance, there were significant main effects for sex and group. Females performed better than males in verbal memory (χ = 9.038, p = 0.003) and obtained a higher emotional intelligence quotient (χ = 13.20, p < 0.001). On the contrary, males obtained better results in working memory (χ = 7.627, p = 0.006). FEP patients significantly underperformed FEM patients in most cognitive domains. There were significant group by sex interactions for few neuropsychological variables, namely processing speed (χ = 4.559, p = 0.033) and verbal fluency (χ = 8.913, p = 0.003).
Differences between sexes were evaluated, but the influence of gender was not considered. Retrospective evaluation of prodromes and substance use. No healthy control group comparator.
The main finding is the presence of significant sex effect and group by sex interaction on specific neurocognitive cognition and emotional intelligence measures. Tailored sex-based early treatment strategies might be implemented.
本研究旨在确定首发躁狂症(FEM)或精神病(FEP)患者的性别差异,以帮助制定关注性别差异的早期治疗策略。
对首次出现 FEM 或 FEP 的患者进行临床、神经心理学(神经认知功能和情绪智力)和功能评估。通过一般线性模型比较组间的这些变量的表现,以性别和组(FEM 与 FEP)为主效应,组与性别的相互作用为次要效应。
总样本包括 113 名患者:FEM=72 名(45.83%为女性),FEP=41 名(46.34%为女性)。大多数临床特征(抑郁、阴性和阳性症状)和社会心理功能(χ=8.815,p=0.003)存在显著的组间主效应(但性别无主效应)。至于神经心理学表现,存在显著的性别和组间主效应。女性在言语记忆方面的表现优于男性(χ=9.038,p=0.003),情绪智力商数更高(χ=13.20,p<0.001)。相反,男性在工作记忆方面的表现更好(χ=7.627,p=0.006)。FEP 患者在大多数认知领域的表现明显差于 FEM 患者。在少数神经心理学变量中,存在显著的组间性别交互作用,即处理速度(χ=4.559,p=0.033)和言语流畅性(χ=8.913,p=0.003)。
评估了性别之间的差异,但未考虑性别影响。对前驱期和物质使用情况进行回顾性评估。无健康对照组。
主要发现是在特定的神经认知和情绪智力测量中存在显著的性别效应和组间性别交互作用。可能实施基于性别的早期治疗策略。